Skip to content
  • food
  • industrial
  • pharma

Sodium acetate

CAS 6131-90-4 · 0/100 · High conf.

Sodium acetate chemical structure

Concern score

0/100Low concern — well-established and permitted without restriction (FDA GRAS; JECFA ADI not specified; EU food additive).
High confidence

Sodium acetate in plain language

What it is

Also known as Sodium acetate trihydrate · Sodium acetate hydrate · Acetic acid, sodium salt, trihydrate · Acetic acid, sodium salt, hydrate (1:1:3) · Sodium acetate (3H2O) · Sodium acetate--water (1/1/3)

Show all 24 names

sodium;acetate;trihydrate · Acetate, sodium, trihydrate · AcONa.3H2O · C2H9NaO5 · CH3CO2Na.3H2O · E-262(I) · Ins NO.262(I) · INS-262(I) · Natrium acetate-3-wasser · Plasmafusin · Sodium acetate (USP) · Sodium acetate trihydrate; Sodium ethanoate trihydrate · Thomaegelin · Tutofusin · UNII-4550K0SC9B · natriumacetate trihydrate · sodium acetate (sodium acetate trihydrate) · sodium acetatetrihydrate

What it does

We don't have a plain-language description for Sodium acetate yet.

Is it a concern?
Low concern: no hazard classifications on record.

Why it's flagged

EPA CPDat observed this chemical in 22 composition records across product categories including Laboratory supplies, Food and drug.

The score describes this ingredient's chemical identity — its hazard profile from published classifications and regulatory status — not the safety of any product it appears in.

Regulation

No restrictions found. Sodium acetate appears in these published regulatory listings.

  • In marketed US drugs
  • Inactive ingredient in US drugs

Recorded in these product areas

  • Found in consumer products
  • Pharma
  • Food
  • Industrial
  • USFDAinactive ingredient database33 entries — 17 administration routes
    • Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.02 %w/vSource →
    • Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: 0.03 %w/wSource →
    • Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.68 %w/vSource →
    • Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: 0.03 %w/vSource →
    • Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: ADJ PHSource →
    • Route: INTRACAVITARY; Dosage form: INJECTION; Potency: 0.1 mlSource →
    • Route: INTRADERMAL; Dosage form: INJECTION; Potency: 1.6 mgSource →
    • Route: INTRALESIONAL; Dosage form: INJECTION; Potency: ADJ PHSource →
    • Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 19 mgSource →
    • Route: INTRAOCULAR; Dosage form: SOLUTION; Maximum daily exposure: 195 mgSource →
    • Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: ADJ PHSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 4239 mgSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 141 mgSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 328 mgSource →
    • Route: INTRAVENOUS; Dosage form: LIQUID; Potency: 0.2 %w/vSource →
    • Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 20 mgSource →
    • Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: 0.39 %w/vSource →
    • Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.08 %w/vSource →
    • Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 2 mgSource →
    • Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.24 %w/vSource →
    • Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 0.1 mgSource →
    • Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 44 mgSource →
    • Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 43 mgSource →
    • Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 12.5 mgSource →
    • Route: PARENTERAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 250 mgSource →
    • Route: SOFT TISSUE; Dosage form: INJECTION; Potency: ADJ PHSource →
    • Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 19 mgSource →
    • Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.16 %w/vSource →
    • Route: SUBCUTANEOUS; Dosage form: LIQUID; Potency: 0.2 %w/vSource →
    • Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: 0.02 %w/vSource →
    • Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: 0.08 %w/vSource →
    • Route: TOPICAL; Dosage form: CREAM; Potency: NASource →
    • Route: TOPICAL; Dosage form: SOLUTION; Potency: NASource →
  • USEPAcommercial use observedEPA CPDat observed this chemical in 22 composition records across product categories including Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Processing aids not otherwise specified.
    • EPA CPDat observed this chemical in 22 composition records across product categories including Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Processing aids not otherwise specified.Source →
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 49 active drug products and 49 total products.
    • FDA NDC lists this ingredient in 49 active drug products and 49 total products.Source →
  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
    • openFDA substance registry classifies this ingredient as chemical.Source →

Expert safety opinions

No expert opinion on file for Sodium acetate. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.

  • JECFA

    Joint FAO/WHO Expert Committee on Food Additives

    No JECFA evaluation on file.

  • EFSA

    European Food Safety Authority

    No EFSA opinion on file.

Evidence & sources

No graded research studies for Sodium acetate yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

7 data sources

Where this comes from

  • EPA Chemical and Products Database

    exposure · updated January 7, 2008

    Open →
  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →
  • FDA Inactive Ingredient Database

    regulatory · updated 2026-01-09

    Open →
  • FDA National Drug Code Directory

    regulatory · updated 2027-12-31

    Open →
  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →
  • openFDA Substance

    registry · updated 2026-05-24

    Open →
  • PubChem Live Enrichment

    chemistry · updated 2026-05-17

    Open →
Reference links (1)
Openfda substance

codexalimentarius.net

Allergen profile

Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.

  • SoyContains · Oral (ingested)

    Source: chemindex_name_match

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Food use

Food-use source coverage is present in the current record.

Good fit

The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.

Fragrance avoidance

No fragrance-linked caution surfaced in the current profile.

Good fit

This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.

Where it has been recorded

How often FDA National Drug Code directory has listed Sodium acetate in a product composition. These are source records, not Greenveil catalog products.

Source records

49

See products using Sodium acetate →

Catalog

Found in these products

Their ingredient lists include Sodium acetate; each product's own rating depends on its whole formula, so it is shown on the product page, not here.